Literature DB >> 31744267

Synchronous Lymphomas: An Uncommon Affair

Manohor Vidhya1.   

Abstract

Entities:  

Keywords:  Composite lymphoma; Hodgkin’s lymphoma; Non-Hodgkin lymphoma

Mesh:

Year:  2019        PMID: 31744267      PMCID: PMC7463205          DOI: 10.4274/tjh.galenos.2019.2019.0187

Source DB:  PubMed          Journal:  Turk J Haematol        ISSN: 1300-7777            Impact factor:   1.831


× No keyword cloud information.
An octogenarian man presented with painless left cervical lymphadenopathy. His past history was insignificant with only a mild reduction in platelets in his recent health check. An excision biopsy of the lymph node revealed a dual population of monotonous small cells with scattered mononucleate and binucleate Reed-Sternberg (RS) cells. Immunostaining confirmed the small cells to be of B-cell phenotype co-expressing CD5 and CD23 and the large cells were CD30+ and CD15+ with weak PAX5 and negative CD20. Epstein-Barr virus results were inconclusive; it was reported as negative as there was a weak and scattered staining pattern and a repeat test was negative. A diagnosis of composite lymphoma, B-small lymphocytic lymphoma with Hodgkin’s lymphoma (HL) was suggested. The bone marrow biopsy revealed involvement of small cell lymphoma (SLL). Synchronous lymphomas are rare tumors composed of two or more lymphomas in the same tissue site that are morphologically and immunophenotypically distinct. NHL and HL represent mutually exclusive entities [1]. HL has been described in patients with chronic lymphocytic leukemia, a variant of Richter syndrome with an incidence of <0.5% [2,3,4], and following immunosuppressive therapy [5]. Our patient presented with two separate immunohistomorphologies. In the series reported by Xiao et al. [6], although the 2 subtypes showed biological differences with clonality studies, the overall clinical risk and significance did not differ. Whether this is a case of a de novo composite lymphoma or a Richter-like variant transformation of a hitherto undetected SLL is unclear, and the patient refused treatment at diagnosis and was lost to follow-up.
  6 in total

1.  Poor prognosis of Hodgkin variant of Richter transformation in chronic lymphocytic leukemia treated with cladribine.

Authors:  Krzysztof Jamroziak; Olga Grzybowska-Izydorczyk; Dorota Jesionek-Kupnicka; Joanna Gora-Tybor; Tadeusz Robak
Journal:  Br J Haematol       Date:  2012-04-16       Impact factor: 6.998

2.  Hodgkin transformation of chronic lymphocytic leukemia: Incidence, outcomes, and comparison to de novo Hodgkin lymphoma.

Authors:  Sameer A Parikh; Thomas M Habermann; Kari G Chaffee; Timothy G Call; Wei Ding; Jose F Leis; William R Macon; Susan M Schwager; Kay M Ristow; Luis F Porrata; Neil E Kay; Susan L Slager; Tait D Shanafelt
Journal:  Am J Hematol       Date:  2015-01-30       Impact factor: 10.047

3.  Epstein-Barr virus-positive B-cell lymphoproliferative disorders arising in immunodeficient patients previously treated with fludarabine for low-grade B-cell neoplasms.

Authors:  Lynne V Abruzzo; Cecilia M Rosales; L Jeffrey Medeiros; Francisco Vega; Rajyalakshmi Luthra; John T Manning; Michael J Keating; Dan Jones
Journal:  Am J Surg Pathol       Date:  2002-05       Impact factor: 6.394

4.  Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion.

Authors:  Wenbin Xiao; Wayne W Chen; Lynn Sorbara; Theresa Davies-Hill; Stefania Pittaluga; Mark Raffeld; Elaine S Jaffe
Journal:  Hum Pathol       Date:  2016-05-14       Impact factor: 3.466

5.  Composite lymphomas: Experience from a tertiary cancer center in Kerala, South India.

Authors:  J A Vasudevan; R A Nair; R Sukumaran; S G Nair
Journal:  Indian J Cancer       Date:  2017 Jan-Mar       Impact factor: 1.224

Review 6.  Current trends in the management of Richter's syndrome.

Authors:  John N Allan; Richard R Furman
Journal:  Int J Hematol Oncol       Date:  2019-01-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.